48 related articles for article (PubMed ID: 12184546)
1. Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials.
Hirota M; Takahashi T; Saito Y; Kawabata R; Nakatsuka R; Imamura H; Motoori M; Makari Y; Takeno A; Kishi K; Adachi S; Miyagaki H; Kurokawa Y; Yamasaki M; Eguchi H; Doki Y
Ann Gastroenterol Surg; 2021 Nov; 5(6):754-766. PubMed ID: 34755007
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review).
Fisher L; Fisher A; Smith PN
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33053671
[TBL] [Abstract][Full Text] [Related]
3. Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term.
Suzuki Y; Ishibashi Y; Omura N; Kawasaki N; Kashiwagi H; Yanaga K; Abo M; Urashima M
J Gastrointest Surg; 2005; 9(7):955-60. PubMed ID: 16137591
[TBL] [Abstract][Full Text] [Related]
4. Metabolic bone disorders after gastrectomy: inevitable or preventable?
Rino Y; Aoyama T; Atsumi Y; Yamada T; Yukawa N
Surg Today; 2022 Feb; 52(2):182-188. PubMed ID: 33630154
[TBL] [Abstract][Full Text] [Related]
5. Early phase metabolic bone disorders after gastrectomy: influence of active vitamin D treatment.
Ichikawa C; Takiguchi N; Koda K; Oda K; Suzuki H; Miyazaki M
Dig Dis Sci; 2002 Aug; 47(8):1886-90. PubMed ID: 12184546
[TBL] [Abstract][Full Text] [Related]
6. Bone disorder and vitamin D after gastric cancer surgery.
Rino Y; Takanashi Y; Yamamoto Y; Inagaki D; Kawamoto M; Harada H; Ashida A; Wada H; Yamada R; Ohshima T; Hatori S; Imada T
Hepatogastroenterology; 2007; 54(77):1596-600. PubMed ID: 17708309
[TBL] [Abstract][Full Text] [Related]
7. Changes in bone metabolism after gastric cancer surgery in male patients: a prospective observational study.
Atsumi Y; Rino Y; Wada H; Kitani Y; Ozawa Y; Aoyama T; Oshima T; Yukawa N; Yoshikawa T; Masuda M
Gastric Cancer; 2019 Jan; 22(1):237-243. PubMed ID: 29748875
[TBL] [Abstract][Full Text] [Related]
8. Oral High-Dose Vitamin D Dissolved in Oil Raised Serum 25-Hydroxy-Vitamin D to Physiological Levels in Obese Patients After Sleeve Gastrectomy-A Double-Blind, Randomized, and Placebo-Controlled Trial.
Wolf E; Utech M; Stehle P; Büsing M; Helfrich HP; Stoffel-Wagner B; Egert S; Alteheld B; Riege R; Knapp A; Ellinger S
Obes Surg; 2016 Aug; 26(8):1821-9. PubMed ID: 26704923
[TBL] [Abstract][Full Text] [Related]
9. Calcium regulating hormones and bone mineral content in patients after subtotal gastrectomy.
Kobayashi S; Takahashi C; Kuroda T; Sugenoya A; Iida F; Katoh K
Surg Today; 1994; 24(4):295-8. PubMed ID: 8038501
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. Gastrectomy osteopenia in the rat: the role of vitamin B12 deficiency and the type of reconstruction of the digestive tract.
Wojtyczka A; Bergé B; Rümenapf G; Schwille PO; Ballanti P; Schreiber M; Fries W; Hohenberger W
Clin Sci (Lond); 1998 Dec; 95(6):735-44. PubMed ID: 9831699
[TBL] [Abstract][Full Text] [Related]
12. Gastric fundectomy in the rat: effects on mineral and bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis.
Rümenapf G; Schwille PO; Erben RG; Schreiber M; Bergé B; Fries W; Schmiedl A; Koroma S; Hohenberger W
Calcif Tissue Int; 1998 Nov; 63(5):433-41. PubMed ID: 9799830
[TBL] [Abstract][Full Text] [Related]
13. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.
Rosenquist C; Fledelius C; Christgau S; Pedersen BJ; Bonde M; Qvist P; Christiansen C
Clin Chem; 1998 Nov; 44(11):2281-9. PubMed ID: 9799755
[TBL] [Abstract][Full Text] [Related]
14. Analytical and clinical evaluation of a method to quantify bone alkaline phosphatase, a marker of osteoblastic activity.
Martin M; Van Hoof V; Couttenye M; Prove A; Blockx P
Anticancer Res; 1997; 17(4B):3167-70. PubMed ID: 9329628
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
